|
Nearly 150 research studies were active in 2001. Additionally,
more than 125 cancer treatment and prevention studies were available
to Park Nicollet patients through the Metro-Minnesota Community Clinical
Oncology Program (CCOP).
 |
CCOP is one of 400 sites chosen
for the largest-ever prostate cancer prevention study - the Selenium
and Vitamin E Cancer Prevention Trials (SELECT) - expected to enroll
more than 32,000 men nationally and take up to 12 years to complete.
|
|
Asthma and Allergy Research
Center is part of a consortium of clinical research sites sponsored
by the American Lung Association. In a collaborative study published
in the New England Journal of Medicine, research found that influenza
vaccines are safe for children and adults with asthma. It was previously
believed that flu vaccine may adversely affect these patients.
|
|
Methodist Hospital's Eating
Disorders Institute launched its research program with a survey of
100 Minnesota family practice physicians about their current screening
and treatment practices and referral sources for patients with eating
disorders.
|
|
An Oncology Research Program
study, "Quality of Life after Breast Carcinoma Surgery: A Comparison
of Three Surgical Procedures," was published in the April issue
of Cancer and highlighted in the "Journal of the American
Medical Association."
|
|
Osteoporosis Center researchers
seeking better ways to identify patients at high risk for fracture
determined that it may be reasonable to use lateral X-ray absorptiometry
for people over age 60 who have osteopenia at the spine or hip. Study
results were presented at the American College of Rheumatology 2001
Annual Meeting.
|
|
Health Research Center received
a grant from Humana Inc. for the study "Employee Evaluation of
a Defined Contribution Product: Post Enrollment Survey." This
study is among the first in the country to evaluate employee responses
to the transition from "defined benefit" health plans to
the new "defined contribution" plans.
|
|
An International Diabetes Center
(IDC) study, "A new noninvasive optical method of glycemic assessment
(Accu-Chek™ D-Tector™): comparison with standard measures
of glucose control in patients at risk for type 2 diabetes,"
was selected for the Presidential Poster Session at the annual scientific
meeting of the American Diabetes Association. The study demonstrated
the benefits of the first technology to screen for diabetes without
drawing blood.
|
Research
studies
|
Martin Lee, MD, Oncology
2001 Researcher of the Year
Past
Researchers
of the Year
|
